Filtered By:
Infectious Disease: Influenza
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 693 results found since Jan 2013.
Racial and Ethnic Differences of Influenza-Associated Pediatric Hospitalizations and Deaths, 2008 –2017
Pediatric Allergy, Immunology, and Pulmonology, Ahead of Print.
Source: Pediatric, Allergy, Immunology, and Pulmonology - April 29, 2022 Category: Respiratory Medicine Authors: Shelease C. O'Bryant Deepa Dongarwar Hamisu M. Salihu Susan Gillespie Source Type: research
Reduced exposure to respiratory viral triggers may explain less health care utilization for children with asthma
It has been known for many decades that viral respiratory infections are a common cause of asthma exacerbations.1 In fact, more than 80% of asthma exacerbations have been attributed to viral illness in school-aged children, mostly caused by the human rhinovirus (HRV), followed by seasonal coronaviruses, and influenza A and B.2 Increased morbidity in children with asthma was noted during the 2009 H1N1 influenza pandemic.3
Source: Annals of Allergy, Asthma and Immunology - April 28, 2022 Category: Allergy & Immunology Authors: Stanley Paul Galant, Tricia Morphew, Louis Ehwerhemuepha Tags: Editorial Source Type: research
H5N1 Vaccine Readied for a Possible Influenza Pandemic H5N1 Vaccine Readied for a Possible Influenza Pandemic
Adjuvanted H5N1 influenza vaccine has been shown to be highly immunogenic in younger and older adults. It is being developed in light of a possible H5N1 influenza pandemic that could cause global harm.Medscape Medical News
Source: Medscape Allergy Headlines - April 8, 2022 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
The Current COVID-19 Booster-Shot Strategy is Not Sustainable, Says FDA ’s Expert Panel
While the currently available COVID-19 vaccines remain effective in protecting people from serious disease, public health experts still face a handful of important questions about the shots and their ability to continue to protect against the virus in coming years. Will a new version of the vaccine be more effective? How long does protection last? Are boosters the only way to extend that protection? Is there a better, more coordinated way to give vaccines and boosters to maximize immunity in the face of an ever-changing virus?
Those were the discussion topics that the U.S. Food and Drug Administration’s Vaccines and ...
Source: TIME: Health - April 7, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Live Attenuated Nasal-Spray Flu Vaccine Safe in Kids With Asthma Live Attenuated Nasal-Spray Flu Vaccine Safe in Kids With Asthma
School-aged children with persistent asthma can safely receive the quadrivalent live attenuated influenza vaccine, new research indicates.Reuters Health Information
Source: Medscape Allergy Headlines - March 31, 2022 Category: Allergy & Immunology Tags: Pediatrics News Source Type: news
Environmental factors and mobility predict COVID-19 seasonality in the Netherlands
CONCLUSIONS: We conclude that the combined mobility and environmental model can adequately predict the seasonality of COVID-19 in a country with a temperate climate like the Netherlands. In this model higher solar radiation, higher temperature and hay fever are related to lower COVID-19 reproduction, and higher mobility to indoor recreation locations is related to an increased COVID-19 spread.PMID:35257688 | DOI:10.1016/j.envres.2022.113030
Source: Environmental Research - March 8, 2022 Category: Environmental Health Authors: Martijn J Hoogeveen Aloys C M Kroes Ellen K Hoogeveen Source Type: research
Nasal Vaccines Could Help Stop COVID-19 From Spreading —If Scientists Can Get Them Right
When SARS-CoV-2, the virus that causes COVID-19, infiltrates the body, it typically enters through the nose or mouth, then takes root and begins replicating.
But what if it could never get a foothold in the upper airways? That’s the promise of nasal COVID-19 vaccines, which are meant to prevent infection by blocking the virus at its point of entry.
There is not yet a nasal COVID-19 vaccine available in the U.S.—and it’s not clear if or when there will be—but multiple research teams in the U.S., including the National Institute of Allergy and Infectious Diseases, and abroad are working on them. Russi...
Source: TIME: Health - February 15, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
The adverse reactions to vaccines practice parameter 10 years on -what have we learned?
CONCLUSION: The risk of reactions to vaccination should be weighed against the risk of suffering a vaccine-preventable disease if the vaccine is withheld. There is no need to ask about egg allergy prior to the administration of influenza vaccines, including on screening forms. In most cases, an allergy to a vaccine constituent is not a contraindication to the vaccine containing it. Patients who have had possible anaphylactic reactions to vaccines should be evaluated by an allergist rather than simply being labeled allergic, because most can go on to receive subsequent doses. Most immediate reactions to COVID-19 vaccines ar...
Source: Annals of Allergy, Asthma and Immunology - February 1, 2022 Category: Allergy & Immunology Authors: John M Kelso Source Type: research
Survey of Influenza/Covid-19 Vaccination of High risk Brooklyn Residents
To learn more about inner-city high-risk patients' knowledge and attitudes regarding influenza and Covid-19 vaccines.
Source: Journal of Allergy and Clinical Immunology - February 1, 2022 Category: Allergy & Immunology Authors: Jodan Pathinathan, Shella Steinberg, Alexander Babazadeh, Mariam Majzoub, Venkatesh Sabhae Gangadharappa, Rauno Joks Source Type: research
Influenza vaccination patterns in an Allergy specialty clinic during COVID-19
We sought to determine the effect of the SARS-COV-2 pandemic on seasonal influenza vaccine patterns in a tertiary care, pediatric Allergy clinic.
Source: Journal of Allergy and Clinical Immunology - February 1, 2022 Category: Allergy & Immunology Authors: Jackson Massanelli, Robbie Pesek, Amika Sood, Kim Cobb, Stacie Jones Source Type: research
